Sustained anti-β-adrenergic effect of melatonin in guinea pig heart papillary muscle

Scandinavian Cardiovascular Journal

Volumn 40, Issue 1, 2006, Pages 37-42

  Arvola, Laila ^a,b   Bertelsen, E ^a   Lochner, A ^c   Ytrehus, K ^b  

^a Kirkenes Hospital   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Adrenergic agonists; cAMP; Contractile force; Guinea pig; Melatonin; Nitric oxide; Papillary muscle; Receptor

Indexed keywords

FORSKOLIN; ISOPRENALINE; MELATONIN; MELATONIN RECEPTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN KINASE C THETA;

ADRENERGIC ACTIVITY; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; EXPOSURE; GUINEA PIG; HEART MUSCLE CONTRACTILITY; HEART PAPILLARY MUSCLE; HEART STIMULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR BLOCKING;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ENZYME INHIBITORS; GUINEA PIGS; MELATONIN; MYOCARDIAL CONTRACTION; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PAPILLARY MUSCLES; RECEPTORS, MELATONIN; TRYPTAMINES;

EID: 32144446156     PISSN: 14017431     EISSN: None     Source Type: Journal    
DOI: 10.1080/14017430500339347     Document Type: Article

References (24)

1. Reiter, RJ. (1991) Pineal melatonin: Cell biology of its synthesis and of its physiological interactions Endocr Rev, 12, pp. 151 - 80.
2. Saarela, S and Vuori, M and Eloranta, E and Vakkuri, O. (1999) Melatonin, a candidate signalling molecule for energy sparing Ornis Fennica, 76, pp. 231 - 5.
3. Witt-Enderby, PA and Bennett, J and Jarzynka, MJ and Firestine, S and Melan, MA. (2003) Melatonin receptors and their regulation: Biochemical and structural mechanisms Life Sci, 72, pp. 2183 - 98.
4. Reiter, RJ and Tan, DX. (2003) Melatonin: A novel protective agent against oxidative injury of the ischemic/reperfused heart Cardiovasc Res, 58, pp. 10 - 9.
5. Sahna, E and Acet, A and Ozer, MK and Olmez, E. (2002) Myocardial ischemia-reperfusion in rats: Reduction in infarct size by either supplemental physiological or pharmacological doses of melatonin J Pineal Res, 33, pp. 234 - 8.
6. Salie, R and Harper, I and Cillie, C and (2001) Melatonin protects against ischaemic-reperfusion myocardial damage J Mol Cell Cardiol, 33, pp. 343 - 57.
7. Xiang, Y and Kobilka, BK. (2003) Myocyte adrenoceptor signaling pathways Science, 300, pp. 1530 - 2.
8. Seamon, KB and Daly, JW. (1986) Forskolin: Its biological and chemical properties Adv Cyclic Nucleotide Protein Phosphorylation Res, 20, pp. 1 - 150.
9. Perlini, S and Khoury, EP and Norton, GR and (1998) Adenosine mediates sustained adrenergic desensitization in the rat heart via activation of protein kinase C Circ Res, 83, pp. 761 - 71.
10. Arvola, L and Hassaf, D and Melnikov, AL and Helgesen, KG and Ytrehus, K. (2002) Adenosine induces prolonged anti-beta-adrenergic effects in guinea-pig papillary muscle Acta Physiol Scand, 175, pp. 11 - 7.
11. Arvola, L and Bertelsen, G and Ytrehus, K. (2003) Sustained anti-beta-adrenergic effect of opioids and bradykinin in guinea-pig papillary muscle Eur J Heart Fail Suppl, 2, pp. 19.
12. Abete, P and Bianco, S and Calabrese, C and (1997) Effects of melatonin in isolated rat papillary muscle FEBS Lett, 412, pp. 79 - 85.
13. Massion, PB and Ferom, O and Dessy, C and Balligand, JL. (2003) Nitric oxide and cardiac function. Ten years after and continuing Circ Res, 93, pp. 388 - 98.
14. 2+ and NO Am J Physiol, 275, pp. H823 - 30.
15. Reading, SA and Barclay, JK. (2002) The inotropic effect of nitric oxide on mammalian papillary muscle is dependent on the level of beta1-adrenergic stimulation Can J Physiol Pharmacol, 80, pp. 569 - 77.
16. Dubocovich, ML and Masana, MI and Iacob, S and Sauri, DM. (1997) Melatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor Naunyn Schmiedebergs Arch Pharmacol, 355, pp. 365 - 75.
17. Sallinen, P and Saarela, S and Ilves, M and Vakkuri, O and Leppaluoto, J. (2005) The expression of MT1 and MT2 melatonin receptor mRNA in several rat tissues Life Sci, 76, pp. 1123 - 34.
18. Naji, L and Carrillo-Vico, A and Guerrero, JM and Calvo, JR. (2004) Expression of membrane and nuclear melatonin receptors in mouse peripheral organs Life Sci, 74, pp. 2227 - 36.
19. Ekmekcioglu, C and Thalhammer, T and Humpeler, S and (2003) The melatonin receptor subtype MT2 is present in the human cardiovascular system J Pineal Res, 35, pp. 40 - 4.
20. Yellon, DM and Downey, JM. (2003) Preconditioning the myocardium: From cellular physiology to clinical cardiology Physiol Rev, 83, pp. 1113 - 51.
21. Leon, J and Acuna-Castroviejo, D and Sainz, RM and Mayo, JC and Tan, DX and Reiter, RJ. (2004) Melatonin and mitochondrial function Life Sci, 75, pp. 765 - 90.
22. Hodges, RR and Shatos, MA and Tarko, RS and Vrouvlianis, J and Gu, J and Dartt, DA. (2005) Nitric Oxide and cGMP Mediate α 1D-Adrenergic Receptor-Stimulated Protein Secretion and p42/p44 MAPK Activation in Rat Lacrimal Gland Invest Ophthalmol Vis Sci, 46, pp. 2781 - 9.
23. McCann, SM and Licinio, J and Wong, ML and Yu, WH and Karanth, S and Rettorri, V. (1998) The nitric oxide hypothesis of aging Exp Gerontol, 33, pp. 813 - 26.
24. Petit, L and Lacroix, I and de Coppet, P and Strosberg, AD and Jockers, R. (1999) Differential signaling of human Mel1a and Mel1b melatonin receptors through the cyclic guanosine 3′-5′-monophosphate pathway Biochem Pharmacol, 58, pp. 633 - 9.